1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Leukoplakia: new trials by email Literature Review of Leukoplakia trials Research Report on Leukoplakia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Topical Photodynamic Therapy With Topical Calcipotriol in Management of Oral Leukoplakia Non-invasive Photo Dynamic Therapy using LED of wavelength ranging from 630-660nm( Fluence 15 J/cm2) as light source and 2.5% TB as photosensitizer, Topical application of Calcipotriol ointment 0.005% twice a day for 4 weeks along with preventive and conventional therapy, Conventional non-invasive management : All subjects in the two groups will receive the same standard conventional non- invasive management advised for OL as per current scientific evidence - Oral Leukoplakia | Phase 3 | Not yet recruiting | Dr. Shalini Gupta | 166 | 2026-04-01 | 2026-03-06 |
| Topical Calcipotriol Versus Photodynamic Therapy in the Treatment of Oral Leukoplakia Calcipotriol 0.005% gel, ALA mediated PDT - Oral Leukoplakia | Phase 2 / Phase 3 | Active not recruiting | Alexandria University | 30 | 2025-07-16 | 2026-06-22 |
| Photodynamic Therapy for Oral Precursor Lesions Aminolaevulinic acid, Methylcellulose Placebo - Leukoplakia, Lichen | Phase 3 | Completed | Medical University of Vienna | 28 | 2011-05-01 | 2017-05-17 |
Neoplasms (3) · Pathological Conditions, Anatomical (3) · Pathological Conditions, Signs and Symptoms (3) · Precancerous Conditions (3) · Head and Neck Neoplasms (2) · Mouth Diseases (2) · Mouth Neoplasms (2) · Neoplasms by Site (2) · Stomatognathic Diseases (2)
5-aminolaevulinic acid-n-pentylester (1) · Gels (1) · Photosensitizing Agents (1) · calcipotriene (1)
Alexandria University (1) · Dr. Shalini Gupta (1) · Medical University of Vienna (1)
Austria (1) · Egypt (1) · India (1)
Eglal M Moussa, PhD oral medicine (1) · Gabriella Dvorak, PD, DMD, MD (1) · Shalini Gupta, MDS, FDSRCS(Edin), FAAOM, MBA (1)